Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Dermapharm EPS Diluted (Quarterly) : 0.5451 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5451 |
| March 31, 2026 | 0.9822 |
| December 31, 2025 | 0.7975 |
| September 30, 2025 | 0.8948 |
| June 30, 2025 | 0.4399 |
| March 31, 2025 | 0.653 |
| December 31, 2024 | 0.4063 |
| September 30, 2024 | 0.6609 |
| June 30, 2024 | 0.3453 |
| March 31, 2024 | 0.8793 |
| December 31, 2023 | -0.0538 |
| September 30, 2023 | 0.502 |
| June 30, 2023 | -0.1857 |
| March 31, 2023 | 0.9845 |
| December 31, 2022 | 0.5663 |
| September 30, 2022 | 0.9808 |
| June 30, 2022 | 0.287 |
| March 31, 2022 | 0.7787 |
| December 31, 2021 | 1.521 |
| Date | Value |
|---|---|
| September 30, 2021 | 1.353 |
| June 30, 2021 | 0.8916 |
| March 31, 2021 | 0.8124 |
| December 31, 2020 | 0.5434 |
| September 30, 2020 | 0.4917 |
| June 30, 2020 | 0.2449 |
| March 31, 2020 | 0.5456 |
| December 31, 2019 | 0.3851 |
| September 30, 2019 | 0.3976 |
| June 30, 2019 | 0.4187 |
| March 31, 2019 | 0.404 |
| December 31, 2018 | 0.3183 |
| September 30, 2018 | 0.482 |
| June 30, 2018 | 0.3692 |
| March 31, 2018 | 0.4882 |
| December 31, 2017 | 0.3256 |
| September 30, 2017 | 0.509 |
| June 30, 2017 | 0.3934 |
| March 31, 2017 | 0.4016 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Avadel Pharmaceuticals Plc | 0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.92M |
| Revenue (Quarterly) | 331.55M |
| Total Expenses (Quarterly) | 304.55M |
| Enterprise Value | 3.471B |
| Gross Profit Margin (Quarterly) | 33.36% |
| Profit Margin (Quarterly) | 8.12% |
| Earnings Yield | 6.75% |
| Operating Earnings Yield | 12.15% |
| Normalized Earnings Yield | 7.912 |